Osteoarthritis: rational approach to treating the individual

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 4, 2006, Pages 721-740

  Jüni, Peter ^a   Reichenbach, Stephan ^a   Dieppe, Paul ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

effect size; management; meta analysis; osteoarthritis; pain

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; CELECOXIB; CHONDROITIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; GLUCOSAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; OMEPRAZOLE; PARACETAMOL; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; ROFECOXIB; RUBEFACIENT;

AGING; ALTERNATIVE MEDICINE; ARTHRALGIA; ARTHROSCOPIC SURGERY; BONE RADIOGRAPHY; BRACE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EFFECT SIZE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; HAND OSTEOARTHRITIS; HEREDITY; HIP OSTEOARTHRITIS; HUMAN; INCIDENCE; JOINT INJURY; JOINT PROSTHESIS; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; LAVAGE; LIFESTYLE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; OBESITY; OCCUPATIONAL THERAPY; ORTHOPEDIC SHOE; OSTEOARTHRITIS; OSTEOTOMY; PAIN ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SELECTION; PHYSICAL DISABILITY; PHYSIOTHERAPY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REOPERATION; REVIEW; RISK FACTOR; SELF CARE; SELF HELP; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYMPTOM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; WALKING AID; WEIGHT REDUCTION;

COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; OSTEOARTHRITIS; PAIN MEASUREMENT; PATIENT CARE PLANNING; RISK FACTORS; SELF CARE; SEVERITY OF ILLNESS INDEX;

EID: 33748496252     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.05.002     Document Type: Review

References (97)

1. In: Murray C.J.L., and Lopez A.D. (Eds). The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2002 (1996), World Health Organization, Geneva
2. Elders M.J. The increasing impact of arthritis on public health. The Journal of Rheumatology 60 supplement (2000) 6-8
3. Dieppe P.A., Reichenbach S., Williams S., et al. Assessing bone loss on radiographs of the knee in osteoarthritis: a cross-sectional study. Arthritis and Rheumatism 52 (2005) 3536-3541
4. Creamer P., and Hochberg M.C. Why does osteoarthritis of the knee hurt - sometimes?. British Journal of Rheumatology 36 (1997) 726-728
5. Felson D.T. Epidemiology of hip and knee osteoartritis. Epidemiologic Reviews 10 (1988) 1-28
6. McAlindon T.E., Cooper C., Kirwan J.R., and Dieppe P.A. Knee pain and disability in the community. British Journal of Rheumatology 31 (1992) 189-192
7. Jüni P., Dieppe P., Donovan J., et al. Population requirement for primary knee replacement surgery: a cross-sectional study. Rheumatology (Oxford) 42 (2003) 516-521
8. McAlindon T.E., Snow S., Cooper C., and Dieppe P.A. Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Annals of the Rheumatic Diseases 51 (1992) 844-849
9. Hill C.L., Gale D.R., Chaisson C.E., et al. Periarticular lesions detected on magnetic resonance imaging: prevalence in knees with and without symptoms. Arthritis and Rheumatism 48 (2003) 2836-2844
10. Lin E.H., Katon W., Von Korff M., et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 290 (2003) 2428-2429
11. Altman R.D. The classification of osteoarthritis. The Journal of Rheumatology 43 supplement (1995) 42-43
12. Lawrence J.S., Bremner J.M., and Bier F. Osteo-arthrosis. Prevalence in the population and relationship between symptoms and x-ray changes. Annals of the Rheumatic Diseases 25 (1966) 1-24
13. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteorthritis of the hip or knee. The Journal of Rheumatology 15 (1988) 1833-1840
14. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
15. McAlindon T.E., LaValley M.P., and Felson D.T. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis. JAMA 284 (2000) 1241
16. Chan A.W., Hrobjartsson A., Haahr M.T., et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291 (2004) 2457-2465
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. (1988), Lawrence Erlbaum, Hillsdale
18. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
19. Dieppe P., Cushnaghan J., Tucker M., et al. The Bristol 'OA500 study': progression and impact of the disease after 8 years. Osteoarthritis Cartilage 8 (2000) 63-68
20. Warsi A., LaValley M.P., Wang P.S., et al. Arthritis self-management education programs: a meta-analyisis of the effect on pain and disability. Arthritis and Rheumatism 48 (2003) 2207-2213
21. Amadio P.J., and Cummings D.M. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research, Clinical and Experimental 34 (1983) 59-66
22. Zoppi M., Peretti G., and Boccard E. Placebo-controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or hip. European Journal of Pain 16 (1995) 42-48
23. Case J.P., Baliunas A.J., and Block J.A. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Archives of Internal Medicine 163 (2003) 169-178
24. Zwahlen M., Jüni P., and Egger M. What now about acetaminophen?. Archives of Internal Medicine 163 (2003) 169-178
25. Pincus T., Koch G., Lei H., et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases 63 (2004) 931-939
26. Miceli-Richard C., Le Bars M., Schmidely N., and Dougados M. Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases 63 (2004) 923-930
27. Neame R., Zhang W., and Doherty M. A historic issue of the Annals: three papers examine paracetamol in osteoarthritis. Annals of the Rheumatic Diseases 63 (2004) 897-900
28. Zhang W., Jones A., and Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases 63 (2004) 901-907
29. Moore R.A., Tramèr M.R., Carroll D., et al. Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316 (1998) 333-338
30. Lin J., Zhang W., Jones A., and Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329 (2004) 324-326
31. McCarthy G.M., and McCarty D.J. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. The Journal of Rheumatology 19 (1992) 604-607
32. Chard J., and Dieppe P. Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe - but there's no good evidence that it works. BMJ 322 (2001) 1439-1440
33. Reginster J.Y., Deroisy R., Rovati L.C., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
34. Pavelka K., Gatterova J., Olejarova M., et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Archives of Internal Medicine 162 (2002) 2113-2123
35. Malaise M., Marcolongo R., Uebelhart D., and Vignon E. Efficacy and tolerability of 800 mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomised, double-blind, multicentre study vs placebo. Litera Rheumatol 24 (1999) 32-42
36. Mazieres B., Combe B., Van A.P., et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. The Journal of Rheumatology 28 (2001) 173-181
37. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454-465
38. Richy F., Bruyere O., Ethgen O., et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Annals of the Rheumatic Diseases 63 (2004) 759-766
39. Scott D., Smith C., Lohmander S., and Chard J.A. Osteoarthritis. In: Godlee F. (Ed). Clinical Evidence. 9th edn. (2003), BMJ, London
40. Gøtzsche P.C. Non-steroidal anti-inflammatory drugs. In: Godlee F. (Ed). Clinical Evidence. 9th edn. (2003), BMJ, London
41. Eccles M., Freemantle N., and Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs vs basic analgesia in treating the pain of degenerative arthritis. BMJ 317 (1998) 526-530
42. Pincus T., Koch G.G., Sokka T., et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol vs acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis and Rheumatism 44 (2001) 1587-1598
43. Wolfe F., Zhao S., and Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients - a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis and Rheumatism 43 (2000) 378-385
44. Courtney P., and Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthritis. Annals of the Rheumatic Diseases 61 (2002) 767-773
45. March L., Irwig L., Schwarz J., et al. n Of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 309 (1994) 1041-1045
46. Wegman A.C., van der Windt D.A., de Haan M., et al. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Annals of the Rheumatic Diseases 62 (2003) 1156-1161
47. Jüni P., Rutjes A.W., and Dieppe P.A. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?. BMJ 324 (2002) 1287-1288
48. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
49. Jüni P., Dieppe P., and Egger M. Risk of myocardial infarction associated with selective COX-2 inhibitors: questions remain. Archives of Internal Medicine 162 (2002) 2639-2642
50. Jüni P., Nartey L., Reichenbach S., et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364 (2004) 2021-2029
51. Spiegel B.M.R., Targownik L., Dulai G.S., and Gralnek I.M. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Annals of Internal Medicine 138 (2003) 795-806
52. Jüni P., and Dieppe P. Older people should NOT be prescribed `coxibs' in place of conventional NSAIDs. Age Ageing 33 (2004) 100-104
53. van Baar M.E., Assendelft W.J., Dekker J., et al. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis and Rheumatism 42 (1999) 1361-1369
54. O'Reilly S.C., Muir K.R., and Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Annals of the Rheumatic Diseases 58 (1999) 15-19
55. Peloquin L., Bravo G., Gauthier P., et al. Effects of a cross-training exercise program in persons with osteoarthritis of the knee. A randomized controlled trial. Journal of Clinical Rheumatology 5 (1999) 126-136
56. Petrella R.J., and Bartha C. Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial. The Journal of Rheumatology 27 (2000) 2215-2221
57. van Baar M.E., Dekker J., Oostendorp R.A.B., et al. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up. Annals of the Rheumatic Diseases 60 (2001) 1123-1130
58. Fransen M., Crosbie J., and Edmonds J. Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial. The Journal of Rheumatology 28 (2001) 156-164
59. Thomas K.S., Muir K.R., Doherty M., et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 325 (2002) 752
60. Hinman R.S., Crossley K.M., McConnell J., and Bennell K.L. Efficacy of knee tape in the management of osteoarthritis of the knee: blinded randomised controlled trial. BMJ 327 (2003) 135
61. Toda Y., and Segal N. Usefulness of an insole with subtalar strapping for analgesia in patients with medial compartment osteoarthritis of the knee. Arthritis and Rheumatism 47 (2002) 468-473
62. Balazs E.A., and Denlinger J.L. Viscosupplementation: a new concept in the treatment of osteoarthritis. The Journal of Rheumatology 20 supplement 39 (1993) 3-9
63. Arroll B., and Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 328 (2004) 869
64. Brandt K.D., Smith Jr. G.N., and Simon L.S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?. Arthritis and Rheumatism 43 (2000) 1192-1203
65. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis and Cartilage 1 (1993) 97-103
66. Lo G.H., LaValley M., McAlindon T., and Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290 (2003) 3115-3121
67. McLaren A.C., Blokker C.P., Fowler P.J., et al. Arthroscopic debridement of the knee for osteoarthrosis. Canadian Journal of Surgery 34 (1991) 595-598
68. Gross D.E., Brenner S.L., Esformes I., and Gross M.L. Arthroscopic treatment of degenerative joint disease of the knee. Orthopedics 14 (1991) 1317-1321
69. Chang R.W., Falconer J., Stulberg S., et al. A randomized, controlled trial of arthroscopic surgery vs closed-needle joint lavage for patients with osteoarthritis of the knee. Arthritis and Rheumatism 36 (1993) 289-295
70. McEldowney A.J., and Weiker G.G. Open-knee Magnuson debridement as conservative treatment for degenerative osteoarthritis of the knee. The Journal of Arthroplasty 10 (1995) 805-809
71. Moseley J.B., O'Malley K., Petersen N.J., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. The New England Journal of Medicine 347 (2002) 81-88
72. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. The New England Journal of Medicine 344 (2001) 1594-1602
73. Fortin P.R., Penrod J.R., Clarke A.E., et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis and Rheumatism 46 (2002) 3327-3330
74. Ashworth M.A., Brule C., Day A., et al. The Development of an Orthopedic Waiting List Algorithm for Elective Total Hip and Total Knee Replacement Surgery (2002), Canadian Health Services Research Foundation, Ottawa, Ontario, Canada
75. Callahan C.M., Drake B.G., Heck D.A., and Dittus R.S. Patient outcomes following uni-compartmental or bi-compartmental knee arthroplasty: a meta analysis. The Journal of Arthroplasty 10 (1995) 141-150
76. Callahan C.M., Drake B.G., Heck D.A., and Dittus R.S. Patient outcomes following tricompartmental total knee replacement: a meta-analysis. JAMA 271 (1994) 1349-1357
77. Hajat S., Fitzpatrick R., Morris R., et al. Does waiting for total hip replacement matter? Prospective cohort study. Journal of Health Services Research & Policy 7 (2002) 19-25
78. Kennedy L.G., Newman J.H., Ackroyd C., and Dieppe P.A. When should we do knee replacements?. Knee 10 (2003) 161-166
79. Murray D.W., Britton A.R., and Bulstrode C.J.K. Loss to follow-up matters. The Journal of Bone and Joint Surgery 79B (1997) 254-257
80. Mahomed N.N., Barrett J.A., Katz J.N., et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. The Journal of Bone and Joint Surgery 85A (2003) 27-32
81. Freund D.A. Assessing and Improving Outcomes: Total Knee Replacement: Patient Outcomes Research Team (PORT): Final Report (1997), Agency for Health Care Policy and Research, Maryland
82. Faulkner A., Kennedy L.G., Baxter K., et al. Effectiveness of hip prostheses in primary total hip replacement. Health Technology Assessment 2 (1998) 1-133
83. Chang R.W., Pellissier J.M., and Hazen G.B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 275 (1996) 858-865
84. Robertsson O., Lewold S., Knutson K., and Lidgren L. The Swedish Knee Arthroplasty Project. Acta Orthopaedica Scandinavica 71 (2003) 7-18
85. Young N.L., Cheah D., Waddell J., and Wright J.G. Patient characteristics that affect the outcome of total hip arthroplasty: a review. Canadian Journal of Surgery 41 (1998) 188-195
86. NIH consensus conference: total hip replacement. NIH consensus development panel on total hip replacement. JAMA 273 (1995) 1950-1956
87. Naylor C.D., and Williams J.I. Primary hip and knee replacement surgery: Ontario criteria for case selection and surgical priority. Quality in Health Care 5 (1995) 20-30
88. Hardorn D.C., and Homes A.C. The New Zealand priority criteria project. BMJ 314 (1997) 131-134
89. Nilsdotter A.K., Aurell Y., Siosteen A.K., et al. Radiographic stage of osteoarthritis or sex of the patient does not predict one year outcome after total hip arthroplasty. Annals of the Rheumatic Diseases 60 (2000) 228-232
90. Chard J.A., Tallon D., and Dieppe P.A. Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Annals of the Rheumatic Diseases 59 (2000) 414-418
91. Emkey R., Rosenthal N., Wu S.C., et al. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. The Journal of Rheumatology 31 (2004) 150-156
92. Messier S.P., Loeser R.F., Miller G.D., et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis and Rheumatism 50 (2004) 1501-1510
93. Bellamy N., Sothern R.B., and Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. The Journal of Rheumatology 17 (1990) 364-372
94. Summers M.N., Haley W.E., Reveille G.S., and Alarcon J.D. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis and Rheumatism 31 (1988) 204-209
95. Zochling J., March L., Lapsley H., et al. Use of complementary medicines for osteoarthritis - a prospective study. Annals of the Rheumatic Diseases 63 (2004) 549-554
96. Weiner D.K., and Ernst E. Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. The Clinical Journal of Pain 20 (2004) 244-255
97. Ezzo J., Hadhazy V., Birch S., et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis and Rheumatism 44 (2001) 819-825